These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4422003)

  • 1. Serum prolactin levels in newly admitted psychiatric patients.
    Meltzer HY; Sachar EJ; Frantz AG
    Adv Biochem Psychopharmacol; 1974; 12(0):299-315. PubMed ID: 4422003
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of psychotic drive disorders].
    Langner E
    Wien Med Wochenschr; 1968 Sep; 118(36):700-2. PubMed ID: 5679053
    [No Abstract]   [Full Text] [Related]  

  • 4. Daytime variation in serum prolactin level in patients receiving oral and depot antipsychotic medication.
    Goode DJ; Meltzer HY; Fang VS
    Biol Psychiatry; 1981 Jul; 16(7):653-62. PubMed ID: 7196775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
    Goode DJ; Meltzer HY; Fang VS
    Psychoneuroendocrinology; 1980 Dec; 5(4):345-51. PubMed ID: 6111101
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder.
    Dean B; Digney A; Sundram S; Thomas E; Scarr E
    Psychiatry Res; 2008 Feb; 158(1):75-8. PubMed ID: 18096247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations between psychotic symptoms and serum prolactin levels.
    Roncoroni D
    Pharmacopsychiatry; 1989 Mar; 22(2):71-5. PubMed ID: 2566181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prolactin response in schizophrenic, schizophreniform, and manic disorders.
    Hitzemann R; Hirschowitz J; Hitzemann B; Garver D
    Biol Psychiatry; 1984 Jun; 19(6):913-8. PubMed ID: 6743725
    [No Abstract]   [Full Text] [Related]  

  • 9. The comparative effectiveness of eight phenothiazines.
    Hanlon TE; Michaux MH; Ota KY; Shaffer JW; Kurland AA
    Psychopharmacologia; 1965 Feb; 7(2):89-106. PubMed ID: 5318926
    [No Abstract]   [Full Text] [Related]  

  • 10. Lithium carbonate treatment in psychiatry.
    Sikes JC; Sikes SC
    Dis Nerv Syst; 1970 Jan; 31(1):52-5. PubMed ID: 5458977
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative research on some clinical and psychopharmacological parameters of reactive paranoid psychoses].
    Masiak M; Marmurowska-Michałowska H; Nagay J; Olajossy M; Perzyński J; Wysocka A
    Psychiatr Pol; 1993; 27(1):63-74. PubMed ID: 8098150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical therapeutic experiences with fluphenazine].
    Pfeiffer WM
    Arzneimittelforschung; 1967 Oct; 17(10):1327-9. PubMed ID: 5632888
    [No Abstract]   [Full Text] [Related]  

  • 14. Are antipsychotic drugs interchangeable?
    Gardos G
    J Nerv Ment Dis; 1974 Nov; 159(5):343-8. PubMed ID: 4612111
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of triphthazine in the treatment of mentae disorders].
    Gurowitsch IJ; Awruzki GJ
    Psychiatr Neurol Med Psychol (Leipz); 1975 May; 27(5):284-91. PubMed ID: 812131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of the effects of perazine, fluphenazine, trifluoperazine, chlorpromazine and haloperidol on primary and deficit symptoms of paranoid schizophrenia].
    Termińska K; Mrowiec W
    Psychiatr Pol; 1989; 23(1):24-30. PubMed ID: 2573098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies of various clinical and psychopharmacological parameters of schizoaffective psychosis and paranoid schizophrenia].
    Masiak M; Perzyński J; Nagay J; Marmurowska-Michałowska H; Olajossy M; Wysocka A
    Psychiatr Pol; 1990; 24(5):1-9. PubMed ID: 2131470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentration and elimination from serum of thioridazine in psychiatric patients.
    Axelsson R; Mårtensson E
    Curr Ther Res Clin Exp; 1976 Feb; 19(2):242-65. PubMed ID: 813963
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin and estradiol serum levels in unmedicated male paranoid schizophrenia patients.
    Segal M; Avital A; Berstein S; Derevenski A; Sandbank S; Weizman A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):378-82. PubMed ID: 17110010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance antipsychotic drugs do prevent relapse: a reply to Tobias and MacDonald.
    Davis JM; Gosenfeld L; Tsai CC
    Psychol Bull; 1976 May; 83(3):431-47. PubMed ID: 6986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.